With reference to earlier communication dated 25th September, 2025 regarding closure of trading window (for the purpose of Financial Results for the quarter and half year ended 30th September, 2025) starting from 29th September, 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter ended 30th September, 2025 are communicated to the Stock Exchanges, Alkem Laboratories has informed that the Financial Results of the Company for the quarter and half year ended 30th September, 2025 having been communicated to the Stock Exchanges, today 13th November, 2025, the trading window shall open on 17th November, 2025.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: